Table 2 Frequency distribution of blood examination data
Variables | Items | |
|---|---|---|
Glucose | HbA1c | |
PATIENT INFORMATION | ||
Number of subjects | 485 | 155 |
Sex | ||
Female | 187 (38.6) | 54 (34.8) |
Male | 298 (61.4) | 101 (65.2) |
Age, years | ||
20–49 | 67 (13.8) | 20 (12.9) |
50–59 | 103 (21.2) | 33 (21.3) |
60–69 | 150 (31.0) | 47 (30.3) |
70< | 165 (34.0) | 55 (35.5) |
Medication | ||
candesartan cilexetil | 177 (36.5) | 51 (32.9) |
losartan potassium | 78 (16.1) | 35 (22.6) |
olmesartan medoxomil | 56 (11.5) | 21 (13.5) |
telmisartan | 56 (11.5) | 18 (11.6) |
valsartan | 118 (24.3) | 30 (19.4) |
DATA INFORMATION | ||
Number of examinations | 2464 | 457 |
Treatment duration | ||
0 = "Baseline" | 733 (29.8) | 150 (32.8) |
1 = "~3 M" | 1068 (43.3) | 132 (28.9) |
2 = "3~6 M" | 377 (15.3) | 89 (19.5) |
3 = "6~12 M" | 286 (11.6) | 86 (18.8) |